Literature DB >> 16638101

Asian contribution to living donor liver transplantation.

Sung-Gyu Lee1.   

Abstract

Although the shortage of brain-dead donor organs is a worldwide problem, the situation is especially serious in Asia because of various cultural and social reasons, and cadaveric organ donation remains below 5 per million population per year. Living donor liver transplantation (LDLT) could provide an alternative for liver graft for patients with acute and chronic end-stage liver disease. This article introduces the important contributions to the development of LDLT by the leading Asian liver transplantation centers. The first successful adult LDLT using a left-lobe graft was reported by Makuuchi et al. from Japan in 1994. To overcome the barrier of graft-size matching for adult patients with use of a left-lobe graft, a trial of adult LDLT using a right-lobe graft with middle hepatic vein was reported with satisfactory outcome by Fan et al. from Hong Kong in 1997. Despite the impressive results of right-lobe LDLT, considerable debate persists concerning donor safety. Lee et al. from Korea initiated modified right-lobe liver grafting with interposition vein grafts to drain anterior segment and two left-lobe liver grafting to overcome graft-size insufficiency and to ensure donor safety in 1999 and 2000, respectively. In addition to technical innovations, indications for liver transplantation have been developed by Asian centers as LDLT activity has increased.

Entities:  

Mesh:

Year:  2006        PMID: 16638101     DOI: 10.1111/j.1440-1746.2006.04283.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  Proposal of new expanded selection criteria using total tumor size and (18)F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria.

Authors:  Seung Duk Lee; Bora Lee; Seong Hoon Kim; Jungnam Joo; Seok-Ki Kim; Young-Kyu Kim; Sang-Jae Park
Journal:  World J Transplant       Date:  2016-06-24

2.  Living donor liver transplant (LDLT) is the way forward in Asia.

Authors:  Mohamed Rela; Mettu Srinivas Reddy
Journal:  Hepatol Int       Date:  2017-01-17       Impact factor: 6.047

Review 3.  Role of positron emission tomography/computed tomography in living donor liver transplantation for hepatocellular carcinoma.

Authors:  Seung Duk Lee; Seong Hoon Kim
Journal:  Hepatobiliary Surg Nutr       Date:  2016-10       Impact factor: 7.293

4.  Why does living donor liver transplantation flourish in Asia?

Authors:  Chao-Long Chen; Catherine S Kabiling; Allan M Concejero
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-10-08       Impact factor: 46.802

Review 5.  Liver transplantation: yesterday, today and tomorrow.

Authors:  Osman Abbasoglu
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

6.  Venous Outflow Reconstruction in Adult Living Donor Liver Transplant: Outcome of a Policy for Right Lobe Grafts without the Middle Hepatic Vein.

Authors:  Mohamed Ghazaly; Mohamad T Badawy; Hosam El-Din Soliman; Magdy El-Gendy; Tarek Ibrahim; Brian R Davidson
Journal:  HPB Surg       Date:  2013-12-30

7.  Clinical Impacts of Donor Types of Living vs. Deceased Donors: Predictors of One-Year Mortality in Patients with Liver Transplantation.

Authors:  Eun Jung Kim; Seungjin Lim; Chong Woo Chu; Je Ho Ryu; Kwangho Yang; Young Mok Park; Byung Hyun Choi; Tae Beom Lee; Su Jin Lee
Journal:  J Korean Med Sci       Date:  2017-08       Impact factor: 2.153

Review 8.  Biliary strictures complicating living donor liver transplantation: Problems, novel insights and solutions.

Authors:  Harshavardhan B Rao; Arjun Prakash; Surendran Sudhindran; Rama P Venu
Journal:  World J Gastroenterol       Date:  2018-05-21       Impact factor: 5.742

Review 9.  Endoscopic management of anastomotic stricture after living-donor liver transplantation.

Authors:  Dong Wook Lee; Jimin Han
Journal:  Korean J Intern Med       Date:  2019-02-25       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.